635 related articles for article (PubMed ID: 16420074)
1. Typical and atypical antipsychotics in bipolar depression.
Gao K; Gajwani P; Elhaj O; Calabrese JR
J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074
[TBL] [Abstract][Full Text] [Related]
2. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.
Gao K; Muzina D; Gajwani P; Calabrese JR
J Clin Psychiatry; 2006 Sep; 67(9):1327-40. PubMed ID: 17017818
[TBL] [Abstract][Full Text] [Related]
4. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence.
Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR
J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
Derry S; Moore RA
BMC Psychiatry; 2007 Aug; 7():40. PubMed ID: 17705840
[TBL] [Abstract][Full Text] [Related]
7. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
Perlis RH; Welge JA; Vornik LA; Hirschfeld RM; Keck PE
J Clin Psychiatry; 2006 Apr; 67(4):509-16. PubMed ID: 16669715
[TBL] [Abstract][Full Text] [Related]
9. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics.
Gianfrancesco FD; Rajagopalan K; Sajatovic M; Wang RH
J Clin Psychiatry; 2006 Feb; 67(2):222-32. PubMed ID: 16566617
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
11. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E
J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
[TBL] [Abstract][Full Text] [Related]
13. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
Gianfrancesco F; Pesa J; Wang RH
J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206
[TBL] [Abstract][Full Text] [Related]
15. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
[TBL] [Abstract][Full Text] [Related]
16. Newer treatment studies for bipolar depression.
Gao K; Calabrese JR
Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics: newer options for mania and maintenance therapy.
Vieta E; Goikolea JM
Bipolar Disord; 2005; 7 Suppl 4():21-33. PubMed ID: 15948764
[TBL] [Abstract][Full Text] [Related]
18. Bipolar depression: the role of atypical antipsychotics.
Post RM; Calabrese JR
Expert Rev Neurother; 2004 Nov; 4(6 Suppl 2):S27-33. PubMed ID: 16279863
[TBL] [Abstract][Full Text] [Related]
19. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
Miller DS; Yatham LN; Lam RW
J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
